Delcath Systems, Inc. Profile Avatar - Palmy Investing

Delcath Systems, Inc.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…

Medical - Specialties
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Delcath Systems, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Delcath Systems, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Delcath Systems, Inc..

End of DCTH's Analysis
CIK: 872912 CUSIP: 24661P807 ISIN: US24661P8077 LEI: - UEI: -
Secondary Listings
DCTH has no secondary listings inside our databases.